COVID-19
-
How misinformation fuels vaccine hesitancy
More than two dozen experts discussed how to combat misinformation about COVID-19 and the vaccines at a virtual conference held Aug. 26.
-
Study: Surgical masks reduce COVID-19 spread
Researchers found that surgical masks impede the spread of COVID-19 and that just a few, low-cost interventions increase mask-wearing compliance.
-
Preparing for the next pandemic
The Stanford School of Medicine and Stanford Graduate School of Business will convene experts in health care, business and government to discuss the global response to the COVID-19 pandemic, lessons for recovery and how to prepare for future health threats.
-
Tips for kids’ back-to-school anxiety
Returning to school as the pandemic stretches on may spark anxiety in young students, but there are approaches parents can use to build children’s resilience.
-
Stanford opens long COVID clinic
With research showing up to 30% of COVID-19 patients experiencing lingering symptoms, Stanford Health Care treats such “long haulers” with multidisciplinary teams.
-
Winslow leads national COVID-19 group
A professor of medicine and former Air Force colonel, Winslow temporarily relocated to Washington to head an interagency group responding to this pandemic and preparing for the next one.
-
Study shows why second vaccine dose effective
Scientists scrutinized Pfizer vaccine recipients’ blood samples to learn exactly what effects the vaccine exerts on the body’s immune system.
-
COVID-19 vaccines prevent infection
A Stanford study finds that the mRNA vaccines, Pfizer and Moderna, offer strong protection against the California variant of the coronavirus.
-
COVID-19 symptoms and prior common colds
In COVID-19 patients whose symptoms were mild, Stanford researchers found that they were more likely than sicker patients to have signs of prior infection by similar, less virulent coronaviruses.
-
Broad-spectrum vaccine may be possible
An immune system stimulant called AS03 could help vaccines protect against multiple viruses by altering the epigenome of the innate immune system.
-
COVID-19 antibody treatment now available
An infusion of monoclonal antibodies can ease COVID-19 symptoms and reduce complications in recently diagnosed, non-hospitalized people at high risk. Now people can refer themselves.
- Administration
- Aging
- Big Data
- Biochemistry
- Bioengineering
- Cancer
- Cardiovascular Health
- Chemical Biology
- Chronic Disease
- COVID-19
- Developmental Biology
- Education
- Genetics
- Global Health
- Health Policy
- Hearing
- Imaging
- Immunology
- Infectious Disease
- Mental Health
- Neuroscience
- Nutrition
- Obituaries
- Pain
- Patient Care
- Pediatrics
- Precision Health
- Preventive Medicine
- Sleep
- Stem Cells
- Surgery
- Technology
- Transplantation
- Urology
- Women's Health